88 related articles for article (PubMed ID: 5319618)
1. [Blood gas studies in a double-blind technic with Bisolvon].
Michel CF
Ther Umsch; 1965 Jul; 22(7):360-1. PubMed ID: 5319618
[No Abstract] [Full Text] [Related]
2. [Respiratory mechanism studies with Bisolvon].
Günthner W
Ther Umsch; 1965 Jul; 22(7):387-8. PubMed ID: 5319622
[No Abstract] [Full Text] [Related]
3. [Cyto-diagnostic test results following sputum provocation with Bisolvon].
Fischnaller M; Schwarzenberg E; Wrbka E
Wien Klin Wochenschr; 1967 Jan; 79(1):1-3. PubMed ID: 5340279
[No Abstract] [Full Text] [Related]
4. [The evaluation of a bronchosercolytic from the pediatric viewpoint (Bisolvon)].
Ayanoglu RN
Ther Umsch; 1965 Jul; 22(7):380-1. PubMed ID: 5319621
[No Abstract] [Full Text] [Related]
5. [Clinical experimental studies on the pharmacodynamic effect of alupent in a double blind test with simultaneous bisolvon therapy].
Seith U
Med Welt; 1966 Sep; 37():1982-4. PubMed ID: 5341649
[No Abstract] [Full Text] [Related]
6. [Expectorants].
Nagaoda S
Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Nov; 20(11):1119-23. PubMed ID: 6763088
[No Abstract] [Full Text] [Related]
7. [In-vitro studies with the secretolytic agent Bisolvon (supplement to preliminary clinico-experimental experiences)].
Bürgi H
Praxis; 1965 Nov; 54(45):1327-30. PubMed ID: 5899263
[No Abstract] [Full Text] [Related]
8. [Recent pharmacological findings with Bisolvon].
Engelhorn R
Ther Umsch; 1965 Jul; 22(7):316-21. PubMed ID: 5834867
[No Abstract] [Full Text] [Related]
9. [Practical trials with Bisolvon, a new bronchial expectorant].
Kleine-Allekotte B
Hippokrates; 1965 Jul; 36(13):521-3. PubMed ID: 5319471
[No Abstract] [Full Text] [Related]
10. [Individual inhalation with Bisolvon].
Bein G
Ther Umsch; 1965 Jul; 22(7):378-80. PubMed ID: 5319620
[No Abstract] [Full Text] [Related]
11. [Bisolvon, a predominantly secrolytic and secromotor expectorant].
Adelmann G
Med Monatsschr; 1965 Jul; 19(7):325-7. PubMed ID: 5320480
[No Abstract] [Full Text] [Related]
12. [Bisolvon capacity inhalations in chronic bronchitis].
Neufang O
Ther Umsch; 1965 Jul; 22(7):377. PubMed ID: 5319619
[No Abstract] [Full Text] [Related]
13. [Experiences with the mucolytic agent Bisolvon: its effect on sputum production].
Gürtler J
Praxis; 1965 Aug; 54(32):948-53. PubMed ID: 5320017
[No Abstract] [Full Text] [Related]
14. Bisolvon.
Drug Ther Bull; 1969 Nov; 7(23):89-90. PubMed ID: 5365833
[No Abstract] [Full Text] [Related]
15. [Introduction on the subject of Bisolvon and surfactant like activity].
Renovanz HD
Dtsch Med J; 1969; 20(9):286-8. PubMed ID: 5397027
[No Abstract] [Full Text] [Related]
16. [The effect of an expectorant on coughing as studied with a new electro-acoustical method].
Krug F
Ther Umsch; 1965 Jul; 22(7):364-5. PubMed ID: 5320019
[No Abstract] [Full Text] [Related]
17. [Experiences with the new secretolytic Bisolvon].
Junge W; Günthner W; Haslreiter E; Hess K; Loos M
Med Klin; 1965 Dec; 60(51):2058-61. PubMed ID: 5332371
[No Abstract] [Full Text] [Related]
18. [Bisolvon, Ingelheim].
Kristoffersen MB
Ugeskr Laeger; 1968 May; 130(22):955-6. PubMed ID: 5699689
[No Abstract] [Full Text] [Related]
19. Pharmacological effects of N-cyclohexyl-N-methyl-(2-amino-3, 5-dibrombenzyl)-ammonium chloride (Bisolvon) with special reference to its expectorant action.
Shimamoto K; Honjo T
Acta Sch Med Univ Kioto; 1967 Jul; 40(1):98-118. PubMed ID: 5591497
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of the CDI System 400 blood gas monitor.
Alston P
Perfusion; 1994; 9(5):373-5. PubMed ID: 7833546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
